Dese de alta para crear alertas sobre sus instrumentos,
eventos económicos y autores favoritos
Registrarse gratis ¿Ya tiene una cuenta? Iniciar sesión
323,240
+2,780
+0,87%
Cotizaciones
Todos los instrumentos
- Todos los instrumentos
- Índices
- Acciones
- ETFs
- Fondos
- M. primas
- Divisas
- Cripto
- Bonos
- Certificados
Por favor, inténtelo con una nueva búsqueda
🚨 ¿Mercados volátiles? Encuentre joyas ocultas para obtener grandes rendimientos
Buscar valores ahora
Axa World Funds - Longevity Economy F Capitalisation Usd (0P00007Y4O)
Añadir/Eliminar de la cartera
Añadir a cartera
- Rating de Morningstar:
- Total activos: 270,42M
Tipo:
Fondo
Mercado:
Luxemburgo
Emisor:
AXA Funds Management S.A.
ISIN:
LU0266013803
Clase de activo:
Acción
AXA World Funds - Framlington Health F Capitalisat
323,240
+2,780
+0,87%
Resumen 0P00007Y4O
En esta página encontrará un perfil detallado de Axa World Funds - Longevity Economy F Capitalisation Usd. Conozca la gestión clave, los activos totales, la estrategia de inversión y la información de contacto de 0P00007Y4O, entre otros datos.
Estrategia de inversión
El objetivo de inversión es buscar el crecimiento de capital a través de inversiones en renta variable y en instrumentos relacionados con la renta variable emitidos por compañías comprometidas con la salud y servicios y productos médicos a nivel mundial. Las inversiones se realizarán en farmacéuticas, compañías biotecnológicas, instrumental médico e instrumentos manufactureros, distribuidores de productos de salud, proveedores y directores médicos y otras compañías de servicios de salud. El proceso de inversión se basa en la filosofía Crecimiento A Un Precio Razonable utilizando un enfoque bottom-up de selección de títulos.
Información de contacto
Lugar
Paseo de la Castellana 93, 6a planta
Madrid,none 28046
Spain
Madrid,none 28046
Spain
Teléfono fijo
+34 91 406 72 18
Fax
+34 91 406 72 01
Web
www.axa-im.es
Ejecutivos destacados
| Nombre | Título | Desde | Hasta |
|---|---|---|---|
| Gregg Bridger | - | 2023 | Ahora |
| Biografía | Gregg Bridger is a fund manager in the global equities team. Prior to joining FOUR, he was employed as a Product Specialist in the Fundamental equities team at Goldman Sachs Asset Management. Previously, Gregg was an assistant portfolio manager in the emerging markets equity team at Credit Suisse. Gregg holds a BA (Hons) in Economics from the University of Leicester and is a CFA Charterholder. | ||
| Stephen Kelly | Portfolio Manager | 2023 | Ahora |
| Biografía | Stephen graduated from the University of Exeter in 1990 with an honours degree in Economics. He joined Olliff & Partners as a trainee in the equity research department where he covered the UK paper and packaging sector. In February 1992 he joined the US Desk at Capel Cure Myers as an assistant Fund Manager and in December 1995 was promoted to Fund Manager.Stephen joined Framlington in 1997 as a Fund Manager on the US Desk responsible for the US and technology. | ||
| Stephen Kelly | Portfolio Manager | 2021 | 2023 |
| Biografía | Stephen graduated from the University of Exeter in 1990 with an honours degree in Economics. He joined Olliff & Partners as a trainee in the equity research department where he covered the UK paper and packaging sector. In February 1992 he joined the US Desk at Capel Cure Myers as an assistant Fund Manager and in December 1995 was promoted to Fund Manager.Stephen joined Framlington in 1997 as a Fund Manager on the US Desk responsible for the US and technology. | ||
| Peter Hughes | Portfolio Manager | 2021 | 2023 |
| Biografía | Peter joined Redwheel in July 2023 as a Partner and Portfolio Manager. He will manage the Redwheel Life Changing Treatments strategy. His ambition for the role is to focus on improving patients’ lives, regardless of where they live by investing in companies facilitating improved health care outcomes while providing long-term capital appreciation for investors. Before Redwheel, Peter was Portfolio Manager of the AXA World Funds Longevity Economy fund and AXA Framlington Health fund, specialising in healthcare. Before this, he held appointments at Architas, in roles covering investment research and relationship management. Peter holds a PhD in biochemistry from University College London. He has a master's degree in chemistry from the University of Surrey and is a CFA Charterholder. He is also an ambassador for the Royal Marsden Cancer Charity. Peter was named as a 2021 Rising Star of Asset Management by Financial News. | ||
| Linden Thomson | - | 2015 | 2021 |
| Dani Saurymper | - | 2015 | 2021 |
| Biografía | Dani Saurymper joined AXA IM in April 2015 as Fund Manager for the AXA Framlington Health Fund. He joined from Barclays Capital where he was a senior equity research analyst covering European healthcare. | ||
| Peter Hughes | Portfolio Manager | 2007 | 2021 |
| Biografía | Peter joined Redwheel in July 2023 as a Partner and Portfolio Manager. He will manage the Redwheel Life Changing Treatments strategy. His ambition for the role is to focus on improving patients’ lives, regardless of where they live by investing in companies facilitating improved health care outcomes while providing long-term capital appreciation for investors. Before Redwheel, Peter was Portfolio Manager of the AXA World Funds Longevity Economy fund and AXA Framlington Health fund, specialising in healthcare. Before this, he held appointments at Architas, in roles covering investment research and relationship management. Peter holds a PhD in biochemistry from University College London. He has a master's degree in chemistry from the University of Surrey and is a CFA Charterholder. He is also an ambassador for the Royal Marsden Cancer Charity. Peter was named as a 2021 Rising Star of Asset Management by Financial News. | ||
| Gemma Game | - | 2009 | 2015 |
| Deane Donnigan | clinical Specialist | 2007 | 2008 |
| Biografía | Deane joined Polar Capital in June 2013 as a senior analyst for the Healthcare team and has over 34 years’ industry experience, including over 15 years within healthcare asset management. She trained as a clinical pharmacist, graduating with a post baccalaureate Doctor of Pharmacy from the University of Georgia. Deane began her career at the Medical College of Georgia, before becoming a clinical specialist in Drug Information and Adult Internal Medicine with Emory University Hospital in Atlanta, Georgia. After several years, she moved to the UK to join Framlington (now AXA Framlington) applying her extensive pharmaceutical expertise working as an analyst for the healthcare unit trust, led by Anthony Milford. She went on to become lead portfolio manager of the Framlington Healthcare and Framlington Biotechnology funds. Deane is both a US and UK citizen. | ||
Escribe tu comentario sobre Axa World Funds - Longevity Economy F Capitalisation Usd
¿Estás seguro que quieres borrar este gráfico?
Eliminar Cancelar
¿Sustituir el gráfico adjunto por un nuevo gráfico?
Sustituir Cancelar
Guía para comentarios
Adjuntar un gráfico al comentario
Confirmar bloqueo
¿Está seguro de que desea bloquear a %USER_NAME%?
Al hacerlo, ni usted ni %USER_NAME% podrán ver las publicaciones del otro en Investing.com.
Se ha agregado correctamente a %USER_NAME% a su lista de usuarios bloqueados
Acaba de desbloquear a esta persona; tiene que esperar 48 horas para poder bloquearla de nuevo.
Denunciar este comentario
Díganos qué piensa de este comentario
Comentario denunciado
Gracias
Su denuncia será examinada por nuestros moderadores